Skip to main content
Clinical Trials/NCT04323982
NCT04323982
Unknown
Not Applicable

Comparison of Traditional Cataract Surgery and Traditional Surgery Combine Triamcinolone Staining of the Anterior Vitreous in Treating Congenital Cataracts

Sun Yat-sen University1 site in 1 country50 target enrollmentMarch 27, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Cataract
Sponsor
Sun Yat-sen University
Enrollment
50
Locations
1
Primary Endpoint
incidence of high intraocular pressure
Last Updated
5 years ago

Overview

Brief Summary

Previously, the investigators have developed a surgical technique to reduce inflammatory response after congenital cataract surgery. This prospective, randomized controlled study aims to compare the prognosis of traditional cataract surgery with traditional surgery combined triamcinolone staining of the anterior vitreous in treating congenital cataracts.

Detailed Description

Surgical technique for congenital cataract is now more and more mature, but many young patients still have obvious postoperative inflammatory response, which might cause visual axial opacification, posterior synechiae and secondary glaucoma. Triamcinolone is used in intraocular injection for its anti-inflammatory effect However, the application of Triamcinolone was reported to be associated with high intraocular pressure. It is necessary to evaluate the safety and effectiveness of using triamcinolone in congenital cataract surgery. In this randomized clinical trial, children with equal degree of congenital cataract in both eyesare enrolled. Patients receive cataract surgery on both eyes on the same day. For each patient, one eye is randomly assigned to undergo traditional surgical procedure, while the fellow eye is undergoing new surgical procedure. The traditional surgical procedure include anterior continuous curvilinear capsulorhexis (ACCC), irrigation/aspiration (I/A), posterior continuous curvilinear capsulorhexis (PCCC), and anterior vitrectomy(A-VIT). Primary intraocular lens implantation (IOL) is performed in children older than age of two. The new surgical procedure is to combine triamcinolone staining of the anterior vitreous on the basis of the traditional surgical procedure. Investigators then compare the incidence of high intraocular pressure, visual axis opacification, uveitis, iris/pupil abnormality, and macular edema between two groups

Registry
clinicaltrials.gov
Start Date
March 27, 2020
End Date
March 25, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Sun Yat-sen University
Responsible Party
Principal Investigator
Principal Investigator

Haotian Lin

Clinical Professor

Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • Age between 3 months and 13 years
  • Uncomplicated bilateral same degree of congenital cataract (≥ 3 mm central dense opacity)
  • Informed consent signed by a parent or legal guardian

Exclusion Criteria

  • Intraocular pressure \>21 mmHg
  • Preterm birth (\<28 weeks)
  • Presence of other ocular diseases (keratitis, keratoleukoma, aniridia, glaucoma, microcornea, persistent hyperplastic primary vitreous) or systemic disease (congenital heart disease, ischemic encephalopathy)
  • History of ocular trauma
  • Previous intraocular surgery

Outcomes

Primary Outcomes

incidence of high intraocular pressure

Time Frame: 5 years

Determined with the Tono-pen.

incidence of visual axis opacification

Time Frame: 5 years

Visual axis obscuration will be evaluated based on the retroillumination.

incidence of uveitis and iris/pupil abnormality

Time Frame: 5 years

Uveitis and iris/pupil abnormality will be evaluated based on the slip lamp examination.

Secondary Outcomes

  • Central corneal thickness(5 years)
  • Best corrected visual acuity(5 years)
  • Central macular thickness(5 years)

Study Sites (1)

Loading locations...

Similar Trials